Kalb Michael Wayne has filed 13 insider transactions across 1 company since November 2024.
Most recent transaction: a option exercise of 7139 shares of CATALYST PHARMACEUTICALS, INC. ($CPRX) on January 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Common Stock, par value $0.001 per share | 7139 | $0.00 | 15,745.0000 | 127,201,954 | 82.95% | 0.01% |
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Restricted Stock Units | 7139 | $0.00 | 632,903.0000 | 127,201,954 | 1.12% | 0.01% |
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | F | Common Stock, par value $0.001 per share | 2080 | $0.00 | 13,665.0000 | 127,201,954 | 13.21% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | F | Common Stock, par value $0.001 per share | 2485 | $0.00 | 8,606.0000 | 127,201,954 | 22.41% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Common Stock, par value $0.001 per share | 6894 | $0.00 | 11,091.0000 | 127,201,954 | 164.26% | 0.01% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | A | Options to purchase common stock | 131536 | $0.00 | 607,235.0000 | 127,201,954 | 27.65% | 0.10% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | A | Restricted Stock Units | 39701 | $0.00 | 646,936.0000 | 127,201,954 | 6.54% | 0.03% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Restricted Stock Units | 6894 | $0.00 | 640,042.0000 | 127,201,954 | 1.07% | 0.01% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Restricted Stock Units | 7138 | $0.00 | 475,699.0000 | 124,943,603 | 1.48% | 0.01% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | F | Common Stock, par value $0.001 per share | 2941 | $0.00 | 4,197.0000 | 124,943,603 | 41.20% | 0.00% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | M | Common Stock, par value $0.001 per share | 7138 | $0.00 | 7,138.0000 | 124,943,603 | 9999.99% | 0.01% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | A | Restricted Stock Units | 20682 | $0.00 | 482,837.0000 | 125,407,279 | 4.48% | 0.02% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Kalb Michael Wayne | Executive Vice President & CFO | A | Options to purchase common stock | 169248 | $0.00 | 462,155.0000 | 125,407,279 | 57.78% | 0.13% |